BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15584879)

  • 21. Global profiling of gene expression in cancer using genomics and proteomics.
    Hanash SM
    Curr Opin Mol Ther; 2001 Dec; 3(6):538-45. PubMed ID: 11804268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applying gene expression microarrays to pulmonary disease.
    Campbell JD; Spira A; Lenburg ME
    Respirology; 2011 Apr; 16(3):407-18. PubMed ID: 21299687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of quantitative proteomic analysis for cancer therapy using "reverse-phase" protein lysate microarrays].
    Nishizuka S; Spurrier B; Honkanen P; Austin J; Wakabayashi G
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):200-5. PubMed ID: 18281757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signature of a silent killer: expression profiling in epithelial ovarian cancer.
    Le Page C; Provencher D; Maugard CM; Ouellet V; Mes-Masson AM
    Expert Rev Mol Diagn; 2004 Mar; 4(2):157-67. PubMed ID: 14995903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications and current challenges of proteomic approaches, focusing on two-dimensional electrophoresis.
    Vercauteren FG; Arckens L; Quirion R
    Amino Acids; 2007 Sep; 33(3):405-14. PubMed ID: 17136510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic Approaches for Biomarker Panels in Cancer.
    Tanase C; Albulescu R; Neagu M
    J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Web-based data warehouse on gene expression in human colorectal cancer.
    Sagynaliev E; Steinert R; Nestler G; Lippert H; Knoch M; Reymond MA
    Proteomics; 2005 Aug; 5(12):3066-78. PubMed ID: 16041676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics: present and future implications in neuro-oncology.
    Micallef J; Gajadhar A; Wiley J; DeSouza LV; Michael Siu KW; Guha A
    Neurosurgery; 2008 Mar; 62(3):539-55; discussion 539-55. PubMed ID: 18425004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innovative proteomic approaches for cancer biomarker discovery.
    Faca V; Krasnoselsky A; Hanash S
    Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.
    Engwegen JY; Gast MC; Schellens JH; Beijnen JH
    Trends Pharmacol Sci; 2006 May; 27(5):251-9. PubMed ID: 16600386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An introduction into proteomics and its clinical applications.
    Ahram M
    Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging biomarker technologies.
    Gunn L; Smith MT
    IARC Sci Publ; 2004; (157):437-50. PubMed ID: 15055310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary proteomics: a tool to discover biomarkers of kidney diseases.
    Dihazi H; Müller GA
    Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet genomics and proteomics in human health and disease.
    Macaulay IC; Carr P; Gusnanto A; Ouwehand WH; Fitzgerald D; Watkins NA
    J Clin Invest; 2005 Dec; 115(12):3370-7. PubMed ID: 16322782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomics: recent applications and new technologies.
    Elrick MM; Walgren JL; Mitchell MD; Thompson DC
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
    Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
    Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling as a tool for basic analysis and clinical application of human cancer.
    García-Escudero R; Paramio JM
    Mol Carcinog; 2008 Aug; 47(8):573-9. PubMed ID: 18324660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.